Correlation of circulating tumor cells (CTCs) expressing stemness and EMT phenotypes with immunosuppressive cells in metastatic breast cancer patients

被引：2
|
作者：
Aggouraki, Despoina [1 ]
Papadaki, Maria [1 ]
Vetsika, Eleni Kyriaki [1 ]
Koutoulaki, Anna [1 ]
Kotsakis, Athanasios [2 ]
Kallergi, Galatea [1 ]
Agelaki, Sofia [2 ]
Mavroudis, Dimitris [2 ]
Georgoulias, Vassilis [2 ]
机构：
[1] Univ Crete, Sch Med, Lab Canc Cell Biol, Iraklion, Greece
[2] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3030
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Aspirin to inhibit the formation and EMT of circulating tumor cells in patients with metastatic colorectal cancer but not breast cancer.
    Ni, Chao
    Yang, Liu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Circulating tumor cells (CTCs) in metastatic breast cancer: Biological value beyond tumor burden.
    Cristofanilli, M.
    Guarneri, V.
    Valero, V.
    Fritsche, H. A.
    Broglio, K. R.
    Reuben, J. M.
    Lara, J.
    Krishnamurthy, S.
    Hortobagyi, G. N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 31S - 31S
  • [23] Truncated HER2 receptor in circulating tumor cells (CTCs) of early and metastatic breast cancer patients
    Kallergi, G.
    Nasias, D.
    Papadaki, M.
    Mavroudis, D.
    Georgoulias, V.
    Agelaki, S.
    [J]. CANCER RESEARCH, 2012, 72
  • [24] Multiple Biomarker Expression in Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients (Pts).
    Somlo, G.
    Hsieh, H. B.
    Curry, D. N.
    Frankel, P.
    Krivacic, R. T.
    Lau, S.
    Lazarus, N.
    Baker, N.
    Swain-Cabriales, S.
    Bruce, R.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 649S - 649S
  • [25] Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses
    Heitmeir, Benedikt
    Deniz, Miriam
    Janni, Wolfgang
    Rack, Brigitte
    Schochter, Fabienne
    Wiesmueller, Lisa
    [J]. CANCERS, 2022, 14 (04)
  • [26] Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs
    Vismara, Marta
    Reduzzi, Carolina
    Daidone, Maria Grazia
    Cappelletti, Vera
    [J]. CIRCULATING TUMOR CELLS IN BREAST CANCER METASTATIC DISEASE, 2020, 1220 : 81 - 91
  • [27] Effect of circulating tumor cells (CTCs) on metastatic progression in colorectal cancer
    Gevorkyan, Yuri
    Kit, Oleg Ivanovich
    Novikova, Inna Arnoldovna
    Soldatkina, Natalya
    Bakhtin, Andrey Vladimirovich
    Shulikov, Pavel B.
    Milakin, Anton G.
    Kolesnikov, Vladimir
    Ilchenko, Sergei A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Circulating Tumor Cells in metastatic Breast Cancer
    Krawczyk, Natalia
    Meier-Stiegen, Franziska
    Katzorke, Nora
    Janni, Wolfgang
    Mueller, Volkmar
    Rack, Brigitte
    Fasching, Peter
    Wallwiener, Diethelm
    Albrecht, Susanne
    Fehm, Tanja
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2014, 74 (11) : 986 - 988
  • [29] Circulating Pancreatic Stellate Cells (Cpscs) and Tumor Cells (Ctcs) in Metastatic Pancreatic Cancer
    Pang, T.
    Xu, Z.
    Pothula, S.
    Becker, T.
    Goldstein, D.
    Pirola, R.
    Wilson, J.
    Apte, M.
    [J]. PANCREAS, 2017, 46 (10) : 1425 - 1425
  • [30] Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib
    Antonia Kalykaki
    Sofia Agelaki
    Galatea Kallergi
    Alexandros Xyrafas
    Dimitris Mavroudis
    Vassilis Georgoulias
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 73 : 685 - 693
12345